CXCL2 and cystic fibrosis: Future longitudinal studies of plasma mediators will be important to understand whether there are immediate and delayed changes in plasma inflammatory mediators following restoration of CFTR, and the roles CXCL2 and CCL2 may play in modulating CF airway inflammation.